Mangalam Drugs & Organics (BOM:532637) 5-Year EBITDA Growth Rate : 4.50% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics 5-Year EBITDA Growth Rate?

Mangalam Drugs & Organics's EBITDA per Share for the three months ended in Dec. 2023 was ₹4.35.

During the past 12 months, Mangalam Drugs & Organics's average EBITDA Per Share Growth Rate was 59.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -31.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Mangalam Drugs & Organics was 75.30% per year. The lowest was -37.70% per year. And the median was 5.90% per year.

Competitive Comparison of Mangalam Drugs & Organics's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mangalam Drugs & Organics's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mangalam Drugs & Organics's 5-Year EBITDA Growth Rate falls into.

Mangalam Drugs & Organics 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Mangalam Drugs & Organics (BOM:532637) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Mangalam Drugs & Organics 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangalam Drugs & Organics (BOM:532637) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

MANGALAM:India

Address

239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001

Website

https://www.mangalamdrugs.com

Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (BOM:532637) Headlines

No Headlines